Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$2.48 USD
+0.30 (13.76%)
Updated Apr 30, 2024 03:59 PM ET
2-Buy of 5 2
B Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Cresco Labs Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -179.85 | -215.84 | -296.83 | -36.56 | -65.30 |
Depreciation/Amortization & Depletion | 69.30 | 57.73 | 44.95 | 40.02 | 11.91 |
Net Change from Assets/Liabilities | 15.22 | 13.45 | -29.07 | 2.97 | 21.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 153.89 | 163.41 | 295.44 | -17.26 | 6.32 |
Net Cash From Operating Activities | 58.56 | 18.74 | 14.49 | -10.83 | -25.19 |
Property & Equipment | -43.68 | -81.70 | -93.88 | -78.27 | -91.67 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1.14 | -75.75 | -14.77 | -28.61 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.90 | 46.26 | 5.69 | 48.93 | 12.69 |
Net Cash from Investing Activities | -44.59 | -36.58 | -163.93 | -44.11 | -107.60 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 3.22 | 20.10 | 6.20 | 3.18 |
Issuance (Repayment) of Debt | 20.18 | 0.00 | 304.64 | 168.06 | 52.28 |
Increase (Decrease) Short-Term Debt | -3.49 | -2.43 | -3.59 | -7.55 | -2.08 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -43.60 | -87.43 | -86.15 | -24.03 | -4.46 |
Net Cash from Financing Activities | -26.91 | -86.64 | 235.01 | 142.67 | 48.91 |
Effect of Exchange Rate Changes | -0.06 | -2.28 | -0.23 | -1.11 | 0.00 |
Net Change In Cash & Equivalents | -12.99 | -106.76 | 85.33 | 86.62 | -83.88 |
Cash at Beginning of Period | 121.51 | 226.10 | 140.77 | 54.15 | 138.03 |
Cash at End of Period | 108.52 | 119.34 | 226.10 | 140.77 | 54.15 |
Diluted Net EPS | -0.54 | -0.71 | -1.22 | -0.39 | NA |
Fiscal Year End for Cresco Labs Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -179.85 | -184.72 | -71.28 | -27.81 |
Depreciation/Amortization & Depletion | NA | 69.30 | 47.35 | 30.34 | 14.65 |
Net Change from Assets/Liabilities | NA | 15.22 | 43.25 | 21.82 | 4.62 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 153.89 | 155.99 | 40.36 | 11.82 |
Net Cash From Operating Activities | NA | 58.56 | 61.87 | 21.24 | 3.27 |
Property & Equipment | NA | -43.68 | -45.51 | -33.21 | -20.50 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | -0.90 | -1.69 | -1.51 | -0.17 |
Net Cash from Investing Activities | NA | -44.59 | -47.19 | -34.72 | -20.67 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 20.18 | 20.18 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | -3.49 | -2.69 | -1.58 | -0.78 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -43.60 | -40.61 | -31.60 | -12.86 |
Net Cash from Financing Activities | NA | -26.91 | -23.13 | -33.18 | -13.64 |
Effect of Exchange Rate Changes | NA | -0.06 | -0.04 | -0.05 | -0.03 |
Net Change In Cash & Equivalents | NA | -12.99 | -8.49 | -46.70 | -31.06 |
Cash at Beginning of Period | NA | 121.51 | 121.51 | 121.51 | 121.51 |
Cash at End of Period | NA | 108.52 | 113.02 | 74.81 | 90.45 |
Diluted Net EPS | NA | 0.01 | -0.34 | -0.12 | -0.09 |